Clin2
NCT07471230Possibly a fitNot yet recruiting

Stem cells for Parkinsonism

Parkinsonism or Parkinson's Disease NosParkinsonism in Diseases Classified Elsewhere

Treatments studied

Part of Brain & nervous system clinical trials.

This trial tests whether a special type of stem cell (from your own body) or tiny particles from those cells (exosomes) can help improve symptoms of Parkinsonism. It's exploring a new way to possibly slow or treat the condition.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
120 people
Ages
48 years to 70 years
Study type
Interventional

Who can take part

  • You are between 40 and 80 years old
  • You have a diagnosis of Parkinsonism (a condition like Parkinson's disease) at a moderate stage (Hoehn and Yahr stage II or III)
  • Your Parkinson's medications have been stable for at least 3 months
  • You have not had cancer (except some skin cancers) in the last 5 years
  • You do not have severe heart disease, a serious infection, or a weakened immune system
  • You have not received any cell therapy in the past

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07467733Not yet recruiting· Phase 1/Phase 2
Stem cell and exosome therapy for spinocerebellar palsy

This trial tests whether a special type of stem cell (neuroinduced mesenchymal stem cells) and their exosomes can safely help people with spinocerebellar palsy. It's an early study focusing on safety and possible improvement in symptoms.

Warsaw
NCT06687837Recruiting· Phase 1
Stem cell therapy for Parkinson's disease

This trial tests whether implanting your own stem cells (made into dopamine-producing brain cells) can improve Parkinson's motor symptoms. You would need to be a candidate for brain surgery and have a stable medication routine.

Boston, Massachusetts
NCT07232147Not yet recruiting· Phase 1
Stem cell therapy trial for Parkinson's disease

This trial tests a new stem cell treatment for people with Parkinson's disease. It's for those whose symptoms affect daily life and who still respond to levodopa but find it less effective over time.

NCT06145711Recruiting
Stem cell therapy for Parkinson's disease

This trial uses special stem cells (made from skin or blood cells) to replace damaged brain cells in people with Parkinson's. The goal is to see if these cells can improve movement and reduce symptoms.

Shanghai, Shanghai Municipality
NCT07102342Recruiting· Phase 1/Phase 2
Cell therapy for Parkinson's disease

This trial tests a new cell treatment for Parkinson's disease. It involves injecting special cells into the brain to see if they can safely replace damaged cells and improve symptoms. It might help people who have had Parkinson's for several years and still respond well to medication.

New York, New York
NCT06858254Not yet recruiting· Phase 1/Phase 2
Stem cell optimization for Parkinson's and related conditions

This trial tests a stem cell treatment to see if it can improve symptoms in people with Parkinson's disease or other similar conditions, like dementia with Lewy bodies or multiple system atrophy. It involves an injection of stem cells harvested from your own bone marrow.

Hear when a new Parkinsonism or Parkinson's Disease Nos trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.